1. Bekker RA, Bykov YU V. Alimemazin: application overview. Psihiatriya i psihofarmakoterapiya im.P.B.Gannushkina. 2016; 18 (6): 10-20. (In Russ.).
2. Zalutskaya NM. Generalized anxiety disorder: current theoretical models and approaches to diagnosis and therapy. Part3. Obozrenie Psihiatrii i Medicinskoj Psihologii im. V.M. Bekhtereva. 2015; 1:83–89 (In Russ.)
3. Kaluev AV, Natt DDzh. On the role of GABA in the pathogenesis of anxiety and depression. Eksperim. i klinich. farmakologiya. 2004; 67(4): 71-76. (In Russ.).
4. Karavaeva TA, Vasilyeva AV, Poltorak SV et al.. Diagnostic algorithm and criteria of generalized anxiety disorder. Obozrenie Psihiatrii i Medicinskoj Psihologii im. V.M. Bekhtereva. 2015; 3:124–130 (In Russ.)
5. Krasnov VN. Anxiety disorders: their place in modern systematics and therapy approaches. Social’naya i klinicheskaya psihiatriya. 2008; 3: 33-38. (In Russ.).